You are using an outdated browser. Please upgrade your browser to improve your experience.

very long chain acyl-CoA dehydrogenase deficiency

Disease Summary
Associated Targets (1)
Tbio

1


GARD Rare
Mondo Description Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is an inherited disorder of mitochondrial long-chain fatty acid oxidation with a variable presentation including: cardiomyopathy, hypoketotic hypoglycemia, liver disease, exercise intolerance and rhabdomyolysis.
Uniprot Description An inborn error of mitochondrial fatty acid beta-oxidation which leads to impaired long-chain fatty acid beta-oxidation. It is clinically heterogeneous, with three major phenotypes: a severe childhood form characterized by early onset, high mortality and high incidence of cardiomyopathy; a milder childhood form with later onset, characterized by hypoketotic hypoglycemia, low mortality and rare cardiomyopathy; an adult form, with isolated skeletal muscle involvement, rhabdomyolysis and myoglobinuria, usually triggered by exercise or fasting.
Disease Ontology Description A lipid metabolism disorder that is characterized by deficiency of the enzyme very long chain acyl-CoA dehydrogenase that results in the inability to convert very long chain fatty acids.
Mondo Term and Equivalent IDs
MONDO:0008723:  very long chain acyl-CoA dehydrogenase deficiency
GARD:0005508: 
ICD10:E71.310: 
NCIT:C98647: 
Orphanet:26793: 
SCTID:237997005: 
UMLS:C3887523: